![Lumea founder featured on Cambridge Health Institute](https://lumeadigital.com/wp-content/uploads/2021/02/In-The-News-5-e1649785648380.png)
Matthew Leavitt, MD, Lumea Founder, had the opportunity to speak at Cambridge Health Institute’s 7th annual Digital Pathology Conference. This Cambridge conference focused on transforming medicine in a digital world. “Seven…
Matthew Leavitt, MD, Lumea Founder, had the opportunity to speak at Cambridge Health Institute’s 7th annual Digital Pathology Conference. This Cambridge conference focused on transforming medicine in a digital world. “Seven…
PathNet uses Lumea digital pathology tech in its practices. PathNet is a coalition of independent pathology groups founded for pathologists by pathologists. Their united goal is to leverage Lumea’s digital…
U.S. Patent 10,734,099 US Abstract A system and method for on-site biopsy management. Patient information is retrieved through a biopsy system. A name of a patient, a biopsy type, and…
U.S. Patent 10,734,100 US Abstract Tissue sample management systems include a central net- work, a medical professional system, and a pathology lab system for processing a tissue sample in a…
Learn how labs are using the Lumea BxChip® to save lab time, increase efficiency, reduce costs, and improve quality for potentially better diagnostic accuracy. Two recent articles praise the BxChip…